Identifying Methylation Biomarkers for Monitoring Bladder Tumors
Conditions
Bladder Cancer
Conditions: official terms
Urinary Bladder Neoplasms
Study Type
Observational
Study Phase
N/A
Study Design
Observational Model: Case Control, Primary Purpose: Screening, Time Perspective: Longitudinal
Intervention
Name: Identifying genes methylated in urine
Type: Procedure
Overall Status
Recruiting
Summary
To investigate the methylation status of 4-6 genes in Urine and matching bladder tissue biopsies, in order to find methylation markers for use in a noninvasive test in monitoring patients with bladder tumors.
Criteria for eligibility
Healthy Volunteers: No
Maximum Age: N/A
Minimum Age: 18 Years
Gender: Both
Criteria: Inclusion Criteria:

- Patients with bladder tumors and patients with benign urinary tract conditions with no clinical suspicion of bladder cancer.

Exclusion Criteria:

- Patients with competing urinary and systemic diseases, pregnant and patients under 18 years of age.
Location
Copenhagen University Hospital at Herlev
Herlev, Copenhagen, Denmark
Status: Recruiting
Contact: Reza R Serizawa, MD - +45 4488 4787 - rerase01@herlevhosp.kbhamt.dk
Start Date
November 2005
Sponsors
Copenhagen University Hospital at Herlev
Source
Copenhagen University Hospital at Herlev
Record processing date
ClinicalTrials.gov processed this data on July 28, 2015
ClinicalTrials.gov page